IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -10.0% ·
aandelenstroom -19.9% ·
netto nieuwe posities -11.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 5.65M | -2.4% | $53.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 5.65M | -2.4% | $53.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 3.10M | -10.9% | $29.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 3.10M | -10.9% | $29.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.02M | +320.9% | $9.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.02M | +320.9% | $9.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Norges Bank ✦ (passief) | 767.04K | -18.7% | $7.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 150.94K | -9.2% | $1.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 129.48K | +10.3% | $1.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 129.48K | +10.3% | $1.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 129.48K | +10.3% | $1.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 129.48K | +10.3% | $1.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 92.37K | -88.1% | $867,336 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 67.75K | -89.7% | $636,154 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 61.01K | Nieuw | $572,875 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Gotham Asset Management | $572,875 | 0.0% |
Verlaten
| Marshall Wace | $12.93M | was 0.0% |
| AQR Capital Management | $92,045 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 282 houders, 266.49M aandelen, $901.79M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.